The clinical benefits of β1-selectivity

Reviews in Contemporary Pharmacotherapy

Volumn 8, Issue 1, 1997, Pages 45-54

  Fogari, Roberto ^a   Zoppi, Annalisa ^a  

^a UNIVERSITY OF PAVIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; ADRENERGIC RECEPTOR STIMULATING AGENT; ATENOLOL; BETA 1 ADRENERGIC RECEPTOR; BETA 1 ADRENERGIC RECEPTOR BLOCKING AGENT; BETA 2 ADRENERGIC RECEPTOR; BISOPROLOL; CHOLESTEROL; ISOPRENALINE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MEPINDOLOL; POTASSIUM; PROPRANOLOL; SALBUTAMOL; TRIACYLGLYCEROL;

ADRENALIN BLOOD LEVEL; AIRWAY RESISTANCE; ANTIHYPERTENSIVE ACTIVITY; ASTHMA; BREATHING; BRONCHODILATATION; CARBOHYDRATE METABOLISM; CHOLESTEROL BLOOD LEVEL; CHRONIC OBSTRUCTIVE LUNG DISEASE; CORONARY ARTERY BLOOD FLOW; DIASTOLIC BLOOD PRESSURE; DRUG SAFETY; DRUG SELECTIVITY; DRUG SPECIFICITY; GLUCOSE METABOLISM; HEART OUTPUT; HEART RATE; HEMODYNAMICS; HUMAN; HYPERTENSION; INSULIN HYPOGLYCEMIA; KIDNEY BLOOD FLOW; LIPID METABOLISM; MENTAL STRESS; NONHUMAN; POTASSIUM BLOOD LEVEL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW; SMOKING; THROMBOCYTE AGGREGATION; TRIACYLGLYCEROL BLOOD LEVEL; VASCULAR RESISTANCE; VASOCONSTRICTION;

EID: 0030951507     PISSN: 09548602     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (12)

1. Abramson EA, Arky RA, Woeber KA. Effects of propranolol on the hormonal and metabolic responses to insulin-induced hypoglycemia. Lancet 1966; ii: 1386-1388.
2. Ahlquist RP. The study of adrenotropic receptors. Am J Physiol 1948; 153: 586-600.
3. Ambrosioni E, Costa FV, Montebugnoli L, Bassein L, Marchesini B, Magnani B. Comparison of antihypertensive efficacy of atenolol, oxprenolol and pindolol at rest and during exercise. Drugs 1983; 25 (Suppl 2): 30-35.
4. Asmar RG, Kerihuel JC, Girerd XJ, Safar ME, Effect of bisoprolol on blood pressure and arterial hemodynamics in systemic hypertension. Am J Cardiol 1991; 68: 61-64.
5. Bailliart O, Kedra AW, Bonnin P, Savin E, Martineaud P-P. Effects of bisoprolol on local vascular resistance. Eur Heart J 1987; 8 (Suppl M): 87-93.
6. Barden TP, Stander RW. Myometrial and cardiovascular effects of an adrenergic blocking drug in human pregnancy. Am J Obstet Gynecol 1968; 101: 91-95.
7. Berglund G, Andersson O. Beta-blockers or diuretics in hypertension? A six-year follow-up of blood pressure and metabolic side-effects. Lancet 1981; 1: 744-747.
8. Berne C, Pollare T, Lithell H. Effects of antihypertensive treatment on insulin sensitivity with special reference to ACE-inhibitors. Diabetes Care 1991; 14 (Suppl 4): 39-47.
9. Bostrom PA, Janzon L, Ohlson O, Westergren A. The effect of beta-blockade on leg blood flow in hypertensive patients with intermittent claudication. Angiology 1986; 37: 149-153.
10. Bracchetti D, Gradnick R, Alberti A et al. A double-blind comparison of bisoprolol and captopril for treatment of essential hypertension in the elderly. Cardiovasc Drugs Ther 1990; 4: 261-264.
11. Breckenridge A. Which beta-blocker? Br Med J 1983; 286: 1085-1088.
12. Breed JGS, Ciampricotti R, Tromp GP, Valster FA, Lageweg E, Van Bortel LMAB. Quality of life perception during antihypertensive treatment: a comparative study of bisoprolol and enalapril. J Cardiovasc Pharmacol 1992; 20: 750-755.